-->
pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-15a |
Genomic Coordinates | chr13: 50049119 - 50049201 |
Synonyms | MIRN15A, hsa-mir-15a, miRNA15A, MIR15A |
Description | Homo sapiens miR-15a stem-loop |
Comment | Reference . |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-15a-5p |
Sequence | 14| UAGCAGCACAUAAUGGUUUGUG |35 |
Evidence | Experimental |
Experiments | Cloned |
SNPs in miRNA | |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling | Circulating MicroRNA Expression Profiling |
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | VEGFA | ||||||||||||||||||||
Synonyms | MVCD1, VEGF, VPF | ||||||||||||||||||||
Description | vascular endothelial growth factor A | ||||||||||||||||||||
Transcript | NM_001025369 | ||||||||||||||||||||
Other Transcripts | NM_001025367 , NM_001025368 , NM_001025366 , NM_001025370 , NM_001033756 , NM_001171622 , NM_001171623 , NM_001171624 , NM_001171625 , NM_001171626 , NM_001171627 , NM_001171628 , NM_001171629 , NM_001171630 , NM_003376 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on VEGFA | |||||||||||||||||||||
3'UTR of VEGFA (miRNA target sites are highlighted) |
>VEGFA|NM_001025369|3'UTR 1 CAAGCCGAGGCGGTGAGCCGGGCAGGAGGAAGGAGCCTCCCTCAGGGTTTCGGGAACCAGATCTCTCACCAGGAAAGACT 81 GATACAGAACGATCGATACAGAAACCACGCTGCCGCCACCACACCATCACCATCGACAGAACAGTCCTTAATCCAGAAAC 161 CTGAAATGAAGGAAGAGGAGACTCTGCGCAGAGCACTTTGGGTCCGGAGGGCGAGACTCCGGCGGAAGCATTCCCGGGCG 241 GGTGACCCAGCACGGTCCCTCTTGGAATTGGATTCGCCATTTTATTTTTCTTGCTGCTAAATCACCGAGCCCGGAAGATT 321 AGAGAGTTTTATTTCTGGGATTCCTGTAGACACACCCACCCACATACATACATTTATATATATATATATTATATATATAT 401 AAAAATAAATATCTCTATTTTATATATATAAAATATATATATTCTTTTTTTAAATTAACAGTGCTAATGTTATTGGTGTC 481 TTCACTGGATGTATTTGACTGCTGTGGACTTGAGTTGGGAGGGGAATGTTCCCACTCAGATCCTGACAGGGAAGAGGAGG 561 AGATGAGAGACTCTGGCATGATCTTTTTTTTGTCCCACTTGGTGGGGCCAGGGTCCTCTCCCCTGCCCAGGAATGTGCAA 641 GGCCAGGGCATGGGGGCAAATATGACCCAGTTTTGGGAACACCGACAAACCCAGCCCTGGCGCTGAGCCTCTCTACCCCA 721 GGTCAGACGGACAGAAAGACAGATCACAGGTACAGGGATGAGGACACCGGCTCTGACCAGGAGTTTGGGGAGCTTCAGGA 801 CATTGCTGTGCTTTGGGGATTCCCTCCACATGCTGCACGCGCATCTCGCCCCCAGGGGCACTGCCTGGAAGATTCAGGAG 881 CCTGGGCGGCCTTCGCTTACTCTCACCTGCTTCTGAGTTGCCCAGGAGACCACTGGCAGATGTCCCGGCGAAGAGAAGAG 961 ACACATTGTTGGAAGAAGCAGCCCATGACAGCTCCCCTTCCTGGGACTCGCCCTCATCCTCTTCCTGCTCCCCTTCCTGG 1041 GGTGCAGCCTAAAAGGACCTATGTCCTCACACCATTGAAACCACTAGTTCTGTCCCCCCAGGAGACCTGGTTGTGTGTGT 1121 GTGAGTGGTTGACCTTCCTCCATCCCCTGGTCCTTCCCTTCCCTTCCCGAGGCACAGAGAGACAGGGCAGGATCCACGTG 1201 CCCATTGTGGAGGCAGAGAAAAGAGAAAGTGTTTTATATACGGTACTTATTTAATATCCCTTTTTAATTAGAAATTAAAA 1281 CAGTTAATTTAATTAAAGAGTAGGGTTTTTTTTCAGTATTCTTGGTTAATATTTAATTTCAACTATTTATGAGATGTATC 1361 TTTTGCTCTCTCTTGCTCTCTTATTTGTACCGGTTTTTGTATATAAAATTCATGTTTCCAATCTCTCTCTCCCTGATCGG 1441 TGACAGTCACTAGCTTATCTTGAACAGATATTTAATTTTGCTAACACTCAGCTCTGCCCTCCCCGATCCCCTGGCTCCCC 1521 AGCACACATTCCTTTGAAATAAGGTTTCAATATACATCTACATACTATATATATATTTGGCAACTTGTATTTGTGTGTAT 1601 ATATATATATATATGTTTATGTATATATGTGATTCTGATAAAATAGACATTGCTATTCTGTTTTTTATATGTAAAAACAA 1681 AACAAGAAAAAATAGAGAATTCTACATACTAAATCTCTCTCCTTTTTTAATTTTAATATTTGTTATCATTTATTTATTGG 1761 TGCTACTGTTTATCCGTAATAATTGTGGGGAAAAGATATTAACATCACGTCTTTGTCTCTAGTGCAGTTTTTCGAGATAT 1841 TCCGTAGTACATATTTATTTTTAAACAACGACAAAGAAATACAGATATATCTTAAAAAAAAAAAAGCATTTTGTATTAAA 1921 GAATTTAATTCTGATCTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
DRVs in gene 3'UTRs | |||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cos-7 |
Location of target site | 3'UTR |
Tools used in this research | FindTar |
Original Description (Extracted from the article) |
...
{This MTI is shown in Fig. 1 and Fig. 2}
... - Ye W; Lv Q; Wong CK; Hu S; Fu C; Hua Z; Cai et al., 2008, PloS one. |
Article |
- Ye W; Lv Q; Wong CK; Hu S; Fu C; Hua Z; Cai et al. - PloS one, 2008
MicroRNAs (miRNAs) guide posttranscriptional repression of mRNAs. Hundreds of miRNAs have been identified but the target identification of mammalian mRNAs is still a difficult task due to a poor understanding of the interaction between miRNAs and the miRNA recognizing element (MRE). In recent research, the importance of the 5' end of the miRNA:MRE duplex has been emphasized and the effect of the tail region addressed, but the role of the central loop has largely remained unexplored. Here we examined the effect of the loop region in miRNA:MRE duplexes and found that the location of the central loop is one of the important factors affecting the efficiency of gene regulation mediated by miRNAs. It was further determined that the addition of a loop score combining both location and size as a new criterion for predicting MREs and their cognate miRNAs significantly decreased the false positive rates and increased the specificity of MRE prediction.
LinkOut: [PMID: 18320040]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 7422.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1
"HITS-CLIP data was present in GSM714643. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 7422.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Jiyoye |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO2.
... - Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al., 2012, The EMBO journal. |
Article |
- Riley KJ; Rabinowitz GS; Yario TA; Luna JM; et al. - The EMBO journal, 2012
Epstein-Barr virus (EBV) controls gene expression to transform human B cells and maintain viral latency. High-throughput sequencing and crosslinking immunoprecipitation (HITS-CLIP) identified mRNA targets of 44 EBV and 310 human microRNAs (miRNAs) in Jijoye (Latency III) EBV-transformed B cells. While 25% of total cellular miRNAs are viral, only three viral mRNAs, all latent transcripts, are targeted. Thus, miRNAs do not control the latent/lytic switch by targeting EBV lytic genes. Unexpectedly, 90% of the 1664 human 3'-untranslated regions targeted by the 12 most abundant EBV miRNAs are also targeted by human miRNAs via distinct binding sites. Half of these are targets of the oncogenic miR-17 approximately 92 miRNA cluster and associated families, including mRNAs that regulate transcription, apoptosis, Wnt signalling, and the cell cycle. Reporter assays confirmed the functionality of several EBV and miR-17 family miRNA-binding sites in EBV latent membrane protein 1 (LMP1), EBV BHRF1, and host CAPRIN2 mRNAs. Our extensive list of EBV and human miRNA targets implicates miRNAs in the control of EBV latency and illuminates viral miRNA function in general.
LinkOut: [PMID: 22473208]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | RPMI-8226 , ARH-77 , OPM-2 , U266 |
Location of target site | 3'UTR |
Tools used in this research | microRNA.org , TargetRank , TargetScan |
Original Description (Extracted from the article) |
...
Western blotting combined with the luciferase reporter assay demonstrated that VEGF-A was a direct target of miR-15a/16.
... - Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai et al., 2013, Carcinogenesis. |
Article |
- Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai et al. - Carcinogenesis, 2013
Deregulated microRNAs (miRNAs) and their roles in cancer development have attracted much attention. Two miRNAs, miR-15a and miR-16, which act as putative tumor suppressor by targeting the oncogene BCL2, have been implicated in cell cycle, apoptosis and proliferation. In this study, we investigated the possible role of miR-15a/16 in the angiogenesis of multiple myeloma (MM). Using a stem-loop quantitative reverse transcription-PCR, we analyzed miR-15a/16 expressions in bone marrow samples from newly diagnosed MM patients and a panel of MM cell lines. miRNA transfection, western blotting analysis and assay of luciferase activity were used to examine whether vascular endothelial growth factor (VEGF) is the target of miR-15a/16. The functional roles of miR-15a/16 on tumorigenesis and angiogenesis were examined by in vitro angiogenesis models and in vivo tumor xenograft model. We showed that miR-15a and miR-16 were significantly underexpressed in primary MM cells as well as in MM cell lines. The aberrant expression of miR-15a/16 was detected especially in advanced stage MM. In human MM cell lines and normal plasma cells, expression of miR-15a/16 inversely correlated with the expression of VEGF-A. Western blotting combined with the luciferase reporter assay demonstrated that VEGF-A was a direct target of miR-15a/16. Ectopic overexpression of miR-15a/16 led to decreased pro-angiogenic activity of MM cells. Finally, infection of lentivirus-miR-15a or lentivirus-miR-16 resulted in significant inhibition of tumor growth and angiogenesis in nude mice. This study suggest that miR-15a/16 could play a role in the tumorigenesis of MM at least in part by modulation of angiogenesis through targeting VEGF-A.
LinkOut: [PMID: 23104180]
|
Experimental Support 7 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | PACs |
Location of target site | 3'UTR |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
VEGF-A and AKT3 Are Direct Targets of Both miR-15a and miR-16
... - Spinetti G; Fortunato O; Caporali A; et al., 2013, Circulation research. |
Article |
- Spinetti G; Fortunato O; Caporali A; et al. - Circulation research, 2013
RATIONALE: Circulating proangiogenic cells (PACs) support postischemic neovascularization. Cardiovascular disease and diabetes mellitus impair PAC regenerative capacities via molecular mechanisms that are not fully known. We hypothesize a role for microRNAs (miRs). Circulating miRs are currently investigated as potential diagnostic and prognostic biomarkers. OBJECTIVE: The objectives were the following: (1) to profile miR expression in PACs from critical limb ischemia (CLI) patients; (2) to demonstrate that miR-15a and miR-16 regulate PAC functions; and (3) to characterize circulating miR-15a and miR-16 and to investigate their potential biomarker value. METHODS AND RESULTS: Twenty-eight miRs potentially able to modulate angiogenesis were measured in PACs from CLI patients with and without diabetes mellitus and controls. miR-15a and miR-16 were further analyzed. CLI-PACs expressed higher level of mature miR-15a and miR-16 and of the primary transcript pri-miR-15a/16-1. miR-15a/16 overexpression impaired healthy PAC survival and migration. Conversely, miR-15a/16 inhibition improved CLI-PAC-defective migration. Vascular endothelial growth factor-A and AKT-3 were validated as direct targets of the 2 miRs, and their protein levels were reduced in miR-15a/16-overexpressing healthy PACs and in CLI-PACs. Transplantation of healthy PACs ex vivo-engineered with anti-miR-15a/16 improved postischemic blood flow recovery and muscular arteriole density in immunodeficient mice. miR-15a and miR-16 were present in human blood, including conjugated to argonaute-2 and in exosomes. Both miRs were increased in the serum of CLI patients and positively correlated with amputation after restenosis at 12 months postrevascularization of CLI type 2 diabetes mellitus patients. Serum miR-15a additionally correlated with restenosis at follow-up. CONCLUSIONS: Ex vivo miR-15a/16 inhibition enhances PAC therapeutic potential, and circulating miR-15a and miR-16 deserves further investigation as a prognostic biomarker in CLI patients undergoing revascularization.
LinkOut: [PMID: 23233752]
|
Experimental Support 8 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 7422.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 9 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 10 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 11 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | DU145 , HUVEC |
Disease | MIMAT0000068 |
Location of target site | 3'UTR |
Tools used in this research | DIANA-microT , miRanda , miRBase Target Database , miRWALK , PicTar , TargetScan |
Original Description (Extracted from the article) |
...
"The luciferase assays showed that compared with control
... - Terzuoli E; Donnini S; Finetti F; Nesi G; et al., 2016, Oncotarget. |
Article |
- Terzuoli E; Donnini S; Finetti F; Nesi G; et al. - Oncotarget, 2016
Prostaglandin E-2 (PGE-2) promotes tumor angiogenesis via paracrine secretion of pro-angiogenic growth factors, such as vascular endothelial growth factor (VEGF). Since miRNAs regulate several cell processes, including angiogenesis, we sought to determine whether they would influence PGE-2-induced VEGF. We compared DU145 and PC3 prostate cancer cells bearing the mPGES-1 enzyme (mPGES-1+/+) and producing PGE-2, with those in which the enzyme was silenced or deleted (mPGES-1-/-). We demonstrated that mPGES-1/PGE-2 signaling decreased Dicer expression and miRNA biogenesis. Genome-wide sequencing of miRNAs revealed that miR-15a and miR-186, associated with expression of VEGF and hypoxia inducible factor-1alpha (HIF-1alpha), were down-regulated in mPGES-1+/+ cells. As a consequence, mPGES-1+/+ tumor cells expressed high levels of VEGF and HIF-1alpha, induced endothelial cells activation and formed highly vascularized tumors. Mir-186 mimic inhibited VEGF expression in mPGES-1+/+ tumor xenografts and reduced tumor growth. In human prostate cancer specimens, mPGES-1 was over-expressed in tumors with high Gleason score, elevated expression of VEGF and HIF-1alpha, high microvessel density and decreased expression of Dicer, miR15a and miR-186. Thus, clear evidence for regulating miRNA processing and VEGF output by intrinsic PGE-2 production provides a means to distinguish between aggressive and indolent prostate tumors and suggests a potential target for controlling tumor progression.
LinkOut: [PMID: 27322147]
|
Experimental Support 12 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293T |
Disease | osteoarthritis |
Location of target site | 3'UTR |
Tools used in this research | miRDB , TargetScan |
Original Description (Extracted from the article) |
...
miR-15a-5p contributes to cell apoptosis and matrix degradation via inhibiting VEGFA//miR-15a-5p regulates viability and matrix degradation of OA and induced a new target for OA diagnosis and therapy
... - Chen H; Tian Y, 2017, Bioscience trends. |
Article |
- Chen H; Tian Y - Bioscience trends, 2017
Previous studies demonstrated that miR-15a-5p was probably associated with human hepatocellular carcinoma, while the function of miR-15a-5p in OA (Osteoarthritis) still remains unknown. Here, we uncovered the potential role of miR-15a-5p on OA pathogenesis and confirmed its predicted target VEGFA (Vascular Endothelial Growth Factor A). Measured by RT-PCR, miR-15a-5p expression increased remarkably while VEGFA expression was significantly decreased in OA chondrocytes compared with normal conditions. According to Luciferase activity assay, miR-15a-5p directly targeted the 3'-UTR of VEGFA to inhibit its expression. Functional analysis including CCK-8 assay and flow cytometry revealed that overexpression of VEGFA or inhibition of miR-15a-5p promoted cell proliferation, suppressed cell apoptosis and reduced matrix degradation in OA chondrocytes. Moreover, rescue assays carried out with both expression of VEGFA and miR-15a-5p demonstrated that miR-15a-5p contributes to cell apoptosis and matrix degradation via inhibiting VEGFA. We further provided evidence that multiple proteins related to matrix synthesis were regulated by miR-15a-5p and VEGFA using Western blot and ELISA assays. Taken together, our findings elucidated an underlying mechanism by which miR-15a-5p regulates viability and matrix degradation of OA and indicated a new target for OA diagnosis and therapy.
LinkOut: [PMID: 27916780]
|
CLIP-seq Support 1 for dataset GSM714642 | |
Method / RBP | HITS-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000372067.3 | 3UTR | GCCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714643 | |
Method / RBP | HITS-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCGAGCCCGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545212 | |
Method / RBP | PAR-CLIP / AGO1 |
---|---|
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545213 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000372067.3 | 3UTR | UAUUUUUCUUGCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545214 | |
Method / RBP | PAR-CLIP / AGO3 |
---|---|
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545215 | |
Method / RBP | PAR-CLIP / AGO4 |
---|---|
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM545216 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000372067.3 | 3UTR | AUUCGCCAUUUUAUUUUUCUUGCUGCUAAAUCACCGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM545217 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM714645 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000372067.3 | 3UTR | CGCCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset SRR359787 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000372067.3 | 3UTR | AUUCGCCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1065668 | |
Method / RBP | PAR-CLIP / AGO1 |
---|---|
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1065669 | |
Method / RBP | PAR-CLIP / AGO1 |
---|---|
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_8 |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM1065670 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000372067.3 | 3UTR | AUUCGCCAUUUUAUUUUUCUUGCUGCUAAAUCACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 14 for dataset SRR1045082 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 15 for dataset GSM1462572 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 16 for dataset GSM1462573 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 17 for dataset GSM1462574 | |
Method / RBP | PAR-CLIP / AGO2 |
---|---|
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000372067.3 | 3UTR | CCAUUUUAUUUUUCUUGCUGCUAAAUCACCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ID | Target |
Description ![]() |
Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT726007 | ZNF91 | zinc finger protein 91 | ![]() |
1 | 1 | |||||||
MIRT552348 | ZNF704 | zinc finger protein 704 | ![]() |
![]() |
2 | 2 | ||||||
MIRT249449 | ZNF691 | zinc finger protein 691 | ![]() |
![]() |
2 | 4 | ||||||
MIRT500321 | ZNF622 | zinc finger protein 622 | ![]() |
![]() |
2 | 9 | ||||||
MIRT504540 | ZNF620 | zinc finger protein 620 | ![]() |
![]() |
2 | 6 | ||||||
MIRT543310 | ZNF585B | zinc finger protein 585B | ![]() |
![]() |
2 | 2 | ||||||
MIRT000922 | ZNF559 | zinc finger protein 559 | ![]() |
![]() |
2 | 1 | ||||||
MIRT456867 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 10 | ||||||
MIRT229343 | ZNF449 | zinc finger protein 449 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564482 | ZNF391 | zinc finger protein 391 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463167 | ZNF367 | zinc finger protein 367 | ![]() |
![]() |
2 | 10 | ||||||
MIRT109240 | ZNF275 | zinc finger protein 275 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551621 | ZNF267 | zinc finger protein 267 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500425 | ZMAT3 | zinc finger matrin-type 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT106292 | ZFHX4 | zinc finger homeobox 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT057729 | ZDHHC16 | zinc finger DHHC-type containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT083265 | ZCCHC3 | zinc finger CCHC-type containing 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT726084 | ZBTB5 | zinc finger and BTB domain containing 5 | ![]() |
1 | 1 | |||||||
MIRT107218 | ZBTB34 | zinc finger and BTB domain containing 34 | ![]() |
![]() |
2 | 2 | ||||||
MIRT175524 | ZBTB33 | zinc finger and BTB domain containing 33 | ![]() |
1 | 1 | |||||||
MIRT564838 | ZBTB16 | zinc finger and BTB domain containing 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545961 | ZBTB10 | zinc finger and BTB domain containing 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT087424 | ZNRF3 | zinc and ring finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT320626 | ZNRF2 | zinc and ring finger 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495146 | ZNRF1 | zinc and ring finger 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT294283 | ZFP28 | ZFP28 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT505116 | YTHDC1 | YTH domain containing 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT552744 | YRDC | yrdC N6-threonylcarbamoyltransferase domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT229860 | YIPF6 | Yip1 domain family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT054283 | YAP1 | Yes associated protein 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT564954 | XKR7 | XK related 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT000282 | WNT3A | Wnt family member 3A | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT564987 | WNK3 | WNK lysine deficient protein kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT000817 | WT1 | Wilms tumor 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT247095 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 4 | ||||||
MIRT258410 | WIPI2 | WD repeat domain, phosphoinositide interacting 2 | ![]() |
![]() |
2 | 3 | ||||||
MIRT003872 | WIPF1 | WAS/WASL interacting protein family member 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT726128 | VPS33B | VPS33B, late endosome and lysosome associated | ![]() |
1 | 1 | |||||||
MIRT726143 | VCL | vinculin | ![]() |
1 | 1 | |||||||
MIRT565041 | VAV2 | vav guanine nucleotide exchange factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT004275 | VEGFA | vascular endothelial growth factor A | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
7 | 17 | |
MIRT003873 | VPS45 | vacuolar protein sorting 45 homolog | ![]() |
![]() |
2 | 1 | ||||||
MIRT075273 | VPS4A | vacuolar protein sorting 4 homolog A | ![]() |
![]() |
2 | 8 | ||||||
MIRT487394 | C10orf54 | V-set immunoregulatory receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT004046 | UCP2 | uncoupling protein 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT000916 | UGP2 | UDP-glucose pyrophosphorylase 2 | ![]() |
![]() |
2 | 1 | ||||||
MIRT000914 | UGDH | UDP-glucose 6-dehydrogenase | ![]() |
![]() |
2 | 1 | ||||||
MIRT089105 | B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT544969 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT128798 | UBE4A | ubiquitination factor E4A | ![]() |
1 | 1 | |||||||
MIRT500580 | USP53 | ubiquitin specific peptidase 53 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546118 | USP48 | ubiquitin specific peptidase 48 | ![]() |
![]() |
2 | 4 | ||||||
MIRT104015 | USP42 | ubiquitin specific peptidase 42 | ![]() |
![]() |
2 | 6 | ||||||
MIRT726166 | USP31 | ubiquitin specific peptidase 31 | ![]() |
1 | 1 | |||||||
MIRT726158 | USP3 | ubiquitin specific peptidase 3 | ![]() |
1 | 1 | |||||||
MIRT066312 | USP15 | ubiquitin specific peptidase 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT170733 | UBE3C | ubiquitin protein ligase E3C | ![]() |
1 | 1 | |||||||
MIRT086005 | UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | ![]() |
![]() |
2 | 2 | ||||||
MIRT464668 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT141279 | UBE2Q2 | ubiquitin conjugating enzyme E2 Q2 | ![]() |
1 | 1 | |||||||
MIRT464751 | UBE2Q1 | ubiquitin conjugating enzyme E2 Q1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT571123 | UBE2H | ubiquitin conjugating enzyme E2 H | ![]() |
![]() |
2 | 2 | ||||||
MIRT102632 | UBN2 | ubinuclein 2 | ![]() |
![]() |
2 | 11 | ||||||
MIRT090688 | U2SURP | U2 snRNP associated SURP domain containing | ![]() |
1 | 1 | |||||||
MIRT545973 | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta | ![]() |
![]() |
2 | 2 | ||||||
MIRT087554 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | ![]() |
![]() |
2 | 2 | ||||||
MIRT005763 | TP53 | tumor protein p53 | ![]() |
1 | 1 | |||||||
MIRT571287 | TTLL5 | tubulin tyrosine ligase like 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT726221 | TUBB | tubulin beta class I | ![]() |
1 | 1 | |||||||
MIRT561404 | TUBB2A | tubulin beta 2A class IIa | ![]() |
![]() |
2 | 2 | ||||||
MIRT004680 | TSPYL2 | TSPY like 2 | ![]() |
![]() |
2 | 1 | ||||||
MIRT465165 | TSC22D2 | TSC22 domain family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT553442 | TPM3 | tropomyosin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454970 | TPM2 | tropomyosin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003886 | TRMT13 | tRNA methyltransferase 13 homolog | ![]() |
![]() |
2 | 1 | ||||||
MIRT518095 | TRIM35 | tripartite motif containing 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051347 | TRIM28 | tripartite motif containing 28 | ![]() |
1 | 1 | |||||||
MIRT000808 | TPI1 | triosephosphate isomerase 1 | ![]() |
1 | 1 | |||||||
MIRT158519 | TNRC6B | trinucleotide repeat containing 6B | ![]() |
![]() |
2 | 5 | ||||||
MIRT726280 | TMEM69 | transmembrane protein 69 | ![]() |
1 | 1 | |||||||
MIRT000823 | TMEM251 | transmembrane protein 251 | ![]() |
![]() |
2 | 1 | ||||||
MIRT505349 | TMEM245 | transmembrane protein 245 | ![]() |
![]() |
2 | 6 | ||||||
MIRT051346 | TMEM214 | transmembrane protein 214 | ![]() |
1 | 1 | |||||||
MIRT466008 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 8 | ||||||
MIRT003891 | TMEM184B | transmembrane protein 184B | ![]() |
![]() |
2 | 1 | ||||||
MIRT553565 | TMEM161B | transmembrane protein 161B | ![]() |
![]() |
2 | 2 | ||||||
MIRT131097 | TMEM138 | transmembrane protein 138 | ![]() |
1 | 1 | |||||||
MIRT726307 | TMEM135 | transmembrane protein 135 | ![]() |
1 | 1 | |||||||
MIRT267254 | TMEM109 | transmembrane protein 109 | ![]() |
1 | 1 | |||||||
MIRT505398 | TMEM100 | transmembrane protein 100 | ![]() |
![]() |
2 | 2 | ||||||
MIRT727028 | TM9SF2 | transmembrane 9 superfamily member 2 | ![]() |
1 | 1 | |||||||
MIRT553620 | TM7SF3 | transmembrane 7 superfamily member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466298 | TM4SF1 | transmembrane 4 L six family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT726238 | TRAM1 | translocation associated membrane protein 1 | ![]() |
1 | 1 | |||||||
MIRT726325 | TIMM13 | translocase of inner mitochondrial membrane 13 | ![]() |
1 | 1 | |||||||
MIRT726322 | TKTL1 | transketolase like 1 | ![]() |
1 | 1 | |||||||
MIRT265056 | TBRG1 | transforming growth factor beta regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565400 | TGFBR3 | transforming growth factor beta receptor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT726317 | TLE4 | transducin like enhancer of split 4 | ![]() |
1 | 1 | |||||||
MIRT726356 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
1 | 1 | |||||||
MIRT465570 | TOB2 | transducer of ERBB2, 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT164952 | TADA2B | transcriptional adaptor 2B | ![]() |
1 | 1 | |||||||
MIRT726339 | TFB1M | transcription factor B1, mitochondrial | ![]() |
1 | 1 | |||||||
MIRT466436 | TFAP2A | transcription factor AP-2 alpha | ![]() |
![]() |
2 | 8 | ||||||
MIRT726348 | TCF3 | transcription factor 3 | ![]() |
1 | 1 | |||||||
MIRT614697 | TRAK1 | trafficking kinesin protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570464 | TLK1 | tousled like kinase 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT448440 | TLL1 | tolloid like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT152274 | TNFSF9 | TNF superfamily member 9 | ![]() |
![]() |
2 | 3 | ||||||
MIRT465926 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 8 | ||||||
MIRT000910 | TIA1 | TIA1 cytotoxic granule associated RNA binding protein | ![]() |
![]() |
2 | 1 | ||||||
MIRT563705 | THRAP3 | thyroid hormone receptor associated protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051350 | TTC1 | tetratricopeptide repeat domain 1 | ![]() |
1 | 1 | |||||||
MIRT160169 | TET3 | tet methylcytosine dioxygenase 3 | ![]() |
1 | 1 | |||||||
MIRT727377 | TECPR2 | tectonin beta-propeller repeat containing 2 | ![]() |
1 | 1 | |||||||
MIRT726360 | TBCCD1 | TBCC domain containing 1 | ![]() |
1 | 1 | |||||||
MIRT726367 | TBC1D20 | TBC1 domain family member 20 | ![]() |
1 | 1 | |||||||
MIRT726372 | TBC1D14 | TBC1 domain family member 14 | ![]() |
1 | 1 | |||||||
MIRT217743 | TBPL1 | TATA-box binding protein like 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT553777 | TAF13 | TATA-box binding protein associated factor 13 | ![]() |
![]() |
2 | 4 | ||||||
MIRT726384 | TASP1 | taspase 1 | ![]() |
1 | 1 | |||||||
MIRT065711 | TARBP2 | TARBP2, RISC loading complex RNA binding subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT196450 | TAOK1 | TAO kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT075249 | SNTB2 | syntrophin beta 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT057906 | STXBP3 | syntaxin binding protein 3 | ![]() |
1 | 1 | |||||||
MIRT726422 | STX17 | syntaxin 17 | ![]() |
1 | 1 | |||||||
MIRT725130 | SYNRG | synergin gamma | ![]() |
![]() |
2 | 2 | ||||||
MIRT500860 | SYPL1 | synaptophysin like 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT553812 | SZRD1 | SUZ RNA binding domain containing 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT302825 | SOCS5 | suppressor of cytokine signaling 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467002 | SSRP1 | structure specific recognition protein 1 | ![]() |
![]() |
2 | 5 | ||||||
MIRT521207 | SBNO1 | strawberry notch homolog 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT300100 | STRADB | STE20-related kinase adaptor beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT551740 | SSU72 | SSU72 homolog, RNA polymerase II CTD phosphatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT054895 | SOX5 | SRY-box 5 | ![]() |
![]() |
2 | 1 | ||||||
MIRT726455 | SRPK1 | SRSF protein kinase 1 | ![]() |
1 | 1 | |||||||
MIRT255333 | SRPRB | SRP receptor beta subunit | ![]() |
![]() |
2 | 5 | ||||||
MIRT500936 | SRPR | SRP receptor alpha subunit | ![]() |
![]() |
2 | 7 | ||||||
MIRT003875 | SKAP2 | src kinase associated phosphoprotein 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT726410 | SUPT16H | SPT16 homolog, facilitates chromatin remodeling subunit | ![]() |
1 | 1 | |||||||
MIRT140146 | SPRED1 | sprouty related EVH1 domain containing 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT500953 | SREK1 | splicing regulatory glutamic acid and lysine rich protein 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT546611 | SALL1 | spalt like transcription factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT084462 | SOWAHC | sosondowah ankyrin repeat domain family member C | ![]() |
![]() |
2 | 4 | ||||||
MIRT051325 | SNX6 | sorting nexin 6 | ![]() |
1 | 1 | |||||||
MIRT505549 | SNX16 | sorting nexin 16 | ![]() |
![]() |
2 | 6 | ||||||
MIRT146496 | SNX11 | sorting nexin 11 | ![]() |
1 | 1 | |||||||
MIRT282532 | SLCO3A1 | solute carrier organic anion transporter family member 3A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT108983 | SLC9A6 | solute carrier family 9 member A6 | ![]() |
1 | 1 | |||||||
MIRT726507 | SLC9A1 | solute carrier family 9 member A1 | ![]() |
1 | 1 | |||||||
MIRT726511 | SLC7A5 | solute carrier family 7 member 5 | ![]() |
1 | 1 | |||||||
MIRT191625 | SLC39A9 | solute carrier family 39 member 9 | ![]() |
![]() |
2 | 6 | ||||||
MIRT713423 | SLC35E2B | solute carrier family 35 member E2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT000908 | SLC35B3 | solute carrier family 35 member B3 | ![]() |
![]() |
2 | 1 | ||||||
MIRT000906 | SLC35A1 | solute carrier family 35 member A1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT550405 | SLC29A1 | solute carrier family 29 member 1 (Augustine blood group) | ![]() |
![]() |
2 | 4 | ||||||
MIRT726545 | SLC25A29 | solute carrier family 25 member 29 | ![]() |
1 | 1 | |||||||
MIRT726548 | SLC25A22 | solute carrier family 25 member 22 | ![]() |
1 | 1 | |||||||
MIRT563090 | SLC25A12 | solute carrier family 25 member 12 | ![]() |
![]() |
2 | 3 | ||||||
MIRT521055 | SLC2A3 | solute carrier family 2 member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT201456 | SNRPB2 | small nuclear ribonucleoprotein polypeptide B2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT726482 | SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | ![]() |
1 | 1 | |||||||
MIRT501089 | SMAD7 | SMAD family member 7 | ![]() |
![]() |
2 | 8 | ||||||
MIRT140820 | SMAD3 | SMAD family member 3 | ![]() |
1 | 1 | |||||||
MIRT133769 | SKI | SKI proto-oncogene | ![]() |
![]() |
2 | 3 | ||||||
MIRT270454 | SIRT4 | sirtuin 4 | ![]() |
1 | 1 | |||||||
MIRT563849 | SMDT1 | single-pass membrane protein with aspartate rich tail 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT443809 | SIDT2 | SID1 transmembrane family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT055421 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 11 | ||||||
MIRT468151 | SH3BP4 | SH3 domain binding protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT270552 | SETD1B | SET domain containing 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT571662 | SERBP1 | SERPINE1 mRNA binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466917 | STK38 | serine/threonine kinase 38 | ![]() |
![]() |
2 | 10 | ||||||
MIRT726462 | SPTLC1 | serine palmitoyltransferase long chain base subunit 1 | ![]() |
1 | 1 | |||||||
MIRT505505 | SRSF1 | serine and arginine rich splicing factor 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT088102 | SEPT2 | septin 2 | ![]() |
1 | 1 | |||||||
MIRT158990 | EPT1 | selenoprotein I | ![]() |
1 | 1 | |||||||
MIRT141243 | SCAMP5 | secretory carrier membrane protein 5 | ![]() |
1 | 1 | |||||||
MIRT117655 | SCAMP4 | secretory carrier membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051342 | SEC63 | SEC63 homolog, protein translocation regulator | ![]() |
1 | 1 | |||||||
MIRT468676 | SEC24A | SEC24 homolog A, COPII coat complex component | ![]() |
![]() |
2 | 4 | ||||||
MIRT505686 | SESTD1 | SEC14 and spectrin domain containing 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT468052 | SIK1 | salt inducible kinase 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT171597 | SUN1 | Sad1 and UNC84 domain containing 1 | ![]() |
1 | 1 | |||||||
MIRT546619 | RUNX1T1 | RUNX1 translocation partner 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474828 | KIAA0226 | RUN and cysteine rich domain containing beclin 1 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT726715 | RNMT | RNA guanine-7 methyltransferase | ![]() |
1 | 1 | |||||||
MIRT726764 | REXO1 | RNA exonuclease 1 homolog | ![]() |
1 | 1 | |||||||
MIRT726712 | RNPS1 | RNA binding protein with serine rich domain 1 | ![]() |
1 | 1 | |||||||
MIRT174781 | RNF38 | ring finger protein 38 | ![]() |
1 | 1 | |||||||
MIRT469090 | RNF168 | ring finger protein 168 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554702 | RNF149 | ring finger protein 149 | ![]() |
![]() |
2 | 2 | ||||||
MIRT148302 | RNF138 | ring finger protein 138 | ![]() |
1 | 1 | |||||||
MIRT726756 | RFWD2 | ring finger and WD repeat domain 2 | ![]() |
1 | 1 | |||||||
MIRT078282 | RPS6KB1 | ribosomal protein S6 kinase B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT726677 | RPS6KA3 | ribosomal protein S6 kinase A3 | ![]() |
1 | 1 | |||||||
MIRT003330 | RPS6 | ribosomal protein S6 | 0 | 1 | ||||||||
MIRT726680 | RPS5 | ribosomal protein S5 | ![]() |
1 | 1 | |||||||
MIRT726685 | RPL36 | ribosomal protein L36 | ![]() |
1 | 1 | |||||||
MIRT539902 | RPL14 | ribosomal protein L14 | ![]() |
![]() |
2 | 4 | ||||||
MIRT726720 | RNH1 | ribonuclease/angiogenin inhibitor 1 | ![]() |
1 | 1 | |||||||
MIRT051319 | RPP30 | ribonuclease P/MRP subunit p30 | ![]() |
1 | 1 | |||||||
MIRT000902 | RNASEL | ribonuclease L | ![]() |
![]() |
2 | 1 | ||||||
MIRT714442 | ARHGAP32 | Rho GTPase activating protein 32 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559536 | ARHGAP12 | Rho GTPase activating protein 12 | ![]() |
![]() |
2 | 5 | ||||||
MIRT512288 | ARHGDIA | Rho GDP dissociation inhibitor alpha | ![]() |
![]() |
2 | 7 | ||||||
MIRT007090 | RECK | reversion inducing cysteine rich protein with kazal motifs | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT682280 | RS1 | retinoschisin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT091667 | RARB | retinoic acid receptor beta | ![]() |
![]() |
2 | 6 | ||||||
MIRT546640 | RTN4 | reticulon 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT438610 | RET | ret proto-oncogene | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT137517 | RCOR1 | REST corepressor 1 | ![]() |
1 | 1 | |||||||
MIRT571431 | RIF1 | replication timing regulatory factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT052930 | REPIN1 | replication initiator 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT726773 | RELT | RELT, TNF receptor | ![]() |
1 | 1 | |||||||
MIRT469415 | REL | REL proto-oncogene, NF-kB subunit | ![]() |
![]() |
2 | 6 | ||||||
MIRT180909 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT505911 | RIMS3 | regulating synaptic membrane exocytosis 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT212604 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | ![]() |
![]() |
2 | 8 | ||||||
MIRT000863 | HRSP12 | reactive intermediate imine deaminase A homolog | ![]() |
![]() |
2 | 1 | ||||||
MIRT505930 | RCAN3 | RCAN family member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT194903 | RBBP6 | RB binding protein 6, ubiquitin ligase | ![]() |
![]() |
2 | 8 | ||||||
MIRT727999 | RHOV | ras homolog family member V | ![]() |
1 | 1 | |||||||
MIRT000900 | RHOT1 | ras homolog family member T1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT132734 | RASSF5 | Ras association domain family member 5 | ![]() |
1 | 1 | |||||||
MIRT154043 | RASSF2 | Ras association domain family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563900 | RAPH1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566122 | RASEF | RAS and EF-hand domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT726789 | RAP2C | RAP2C, member of RAS oncogene family | ![]() |
1 | 1 | |||||||
MIRT051322 | RGPD5 | RANBP2-like and GRIP domain containing 5 | ![]() |
1 | 1 | |||||||
MIRT543801 | RALGAPB | Ral GTPase activating protein non-catalytic beta subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT000898 | RAD51C | RAD51 paralog C | ![]() |
![]() |
2 | 1 | ||||||
MIRT106733 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | ![]() |
![]() |
2 | 3 | ||||||
MIRT554965 | RACGAP1 | Rac GTPase activating protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT000804 | RAB9B | RAB9B, member RAS oncogene family | ![]() |
1 | 1 | |||||||
MIRT726812 | RAB40B | RAB40B, member RAS oncogene family | ![]() |
1 | 1 | |||||||
MIRT274741 | RAB3IP | RAB3A interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT555035 | RAB23 | RAB23, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT000812 | RAB21 | RAB21, member RAS oncogene family | ![]() |
![]() |
2 | 1 | ||||||
MIRT716436 | RAB15 | RAB15, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT726826 | RAB11FIP2 | RAB11 family interacting protein 2 | ![]() |
1 | 1 | |||||||
MIRT051324 | PDHX | pyruvate dehydrogenase complex component X | ![]() |
1 | 1 | |||||||
MIRT146351 | PNPO | pyridoxamine 5'-phosphate oxidase | ![]() |
1 | 1 | |||||||
MIRT574062 | PROSC | pyridoxal phosphate binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT003880 | PWWP2A | PWWP domain containing 2A | ![]() |
![]() |
2 | 1 | ||||||
MIRT006998 | PURA | purine rich element binding protein A | ![]() |
![]() |
2 | 2 | ||||||
MIRT098827 | PCMT1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase | ![]() |
1 | 1 | |||||||
MIRT130380 | PTPRJ | protein tyrosine phosphatase, receptor type J | ![]() |
1 | 1 | |||||||
MIRT555143 | PTPRD | protein tyrosine phosphatase, receptor type D | ![]() |
![]() |
2 | 2 | ||||||
MIRT144019 | PSKH1 | protein serine kinase H1 | ![]() |
1 | 1 | |||||||
MIRT051343 | PTAR1 | protein prenyltransferase alpha subunit repeat containing 1 | ![]() |
1 | 1 | |||||||
MIRT191454 | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT726874 | PPP6C | protein phosphatase 6 catalytic subunit | ![]() |
1 | 1 | |||||||
MIRT277504 | PPP2R5C | protein phosphatase 2 regulatory subunit B'gamma | ![]() |
![]() |
2 | 4 | ||||||
MIRT100207 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485215 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | ![]() |
![]() |
2 | 8 | ||||||
MIRT163253 | PRKCD | protein kinase C delta | ![]() |
1 | 1 | |||||||
MIRT555229 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT574542 | PDIA6 | protein disulfide isomerase family A member 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT726853 | PSMB5 | proteasome subunit beta 5 | ![]() |
1 | 1 | |||||||
MIRT051335 | PSMC4 | proteasome 26S subunit, ATPase 4 | ![]() |
1 | 1 | |||||||
MIRT543529 | PRSS21 | protease, serine 21 | ![]() |
![]() |
2 | 2 | ||||||
MIRT186371 | PNRC2 | proline rich nuclear receptor coactivator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT246938 | PRRC2C | proline rich coiled-coil 2C | ![]() |
1 | 1 | |||||||
MIRT051323 | PREB | prolactin regulatory element binding | ![]() |
1 | 1 | |||||||
MIRT000888 | PDCD6IP | programmed cell death 6 interacting protein | ![]() |
![]() |
2 | 1 | ||||||
MIRT000810 | PDCD4 | programmed cell death 4 | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT542837 | PDCD1 | programmed cell death 1 | ![]() |
![]() |
2 | 7 | ||||||
MIRT576100 | Pdcd1 | programmed cell death 1 | ![]() |
![]() |
2 | 5 | ||||||
MIRT003882 | CCDC111 | primase and DNA directed polymerase | ![]() |
![]() |
2 | 1 | ||||||
MIRT501506 | PRICKLE2 | prickle planar cell polarity protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555278 | PRDM4 | PR/SET domain 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT726902 | POU2AF1 | POU class 2 associating factor 1 | ![]() |
1 | 1 | |||||||
MIRT521818 | POM121C | POM121 transmembrane nucleoporin C | ![]() |
![]() |
2 | 2 | ||||||
MIRT080011 | GALNT1 | polypeptide N-acetylgalactosaminyltransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT542810 | PHC3 | polyhomeotic homolog 3 | ![]() |
![]() |
2 | 3 | ||||||
MIRT547069 | PNISR | PNN interacting serine and arginine rich protein | ![]() |
![]() |
2 | 3 | ||||||
MIRT000892 | PMS1 | PMS1 homolog 1, mismatch repair system component | ![]() |
![]() |
2 | 1 | ||||||
MIRT506138 | PLRG1 | pleiotropic regulator 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT055811 | PLEKHA1 | pleckstrin homology domain containing A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT196275 | PAFAH1B1 | platelet activating factor acetylhydrolase 1b regulatory subunit 1 | ![]() |
1 | 1 | |||||||
MIRT179008 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506166 | PLAG1 | PLAG1 zinc finger | ![]() |
![]() |
2 | 9 | ||||||
MIRT000894 | PNN | pinin, desmosome associated protein | ![]() |
![]() |
2 | 1 | ||||||
MIRT100566 | PIM1 | Pim-1 proto-oncogene, serine/threonine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT492715 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT175232 | PSAT1 | phosphoserine aminotransferase 1 | ![]() |
![]() |
2 | 7 | ||||||
MIRT000890 | PHKB | phosphorylase kinase regulatory subunit beta | ![]() |
![]() |
2 | 1 | ||||||
MIRT506194 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT547233 | PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT555431 | PPAP2B | phospholipid phosphatase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051311 | PLA2G2D | phospholipase A2 group IID | ![]() |
1 | 1 | |||||||
MIRT314051 | PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT726967 | PGD | phosphogluconate dehydrogenase | ![]() |
1 | 1 | |||||||
MIRT471495 | PDE4D | phosphodiesterase 4D | ![]() |
![]() |
2 | 4 | ||||||
MIRT471038 | PISD | phosphatidylserine decarboxylase | ![]() |
![]() |
2 | 10 | ||||||
MIRT726287 | TMEM55B | phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 | ![]() |
1 | 1 | |||||||
MIRT093682 | PI4K2B | phosphatidylinositol 4-kinase type 2 beta | ![]() |
![]() |
2 | 6 | ||||||
MIRT571824 | PHF19 | PHD finger protein 19 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 2 | |||
MIRT547131 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT438163 | PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT159580 | PEX13 | peroxisomal biogenesis factor 13 | ![]() |
1 | 1 | |||||||
MIRT726974 | PEX12 | peroxisomal biogenesis factor 12 | ![]() |
1 | 1 | |||||||
MIRT051339 | PRDX3 | peroxiredoxin 3 | ![]() |
1 | 1 | |||||||
MIRT317722 | PPIL1 | peptidylprolyl isomerase like 1 | ![]() |
![]() |
2 | 7 | ||||||
MIRT506112 | PPIG | peptidylprolyl isomerase G | ![]() |
![]() |
2 | 6 | ||||||
MIRT248550 | PDIK1L | PDLIM1 interacting kinase 1 like | ![]() |
1 | 1 | |||||||
MIRT051315 | PCF11 | PCF11 cleavage and polyadenylation factor subunit | ![]() |
1 | 1 | |||||||
MIRT074530 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT082985 | PNPLA6 | patatin like phospholipase domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT727021 | PANK1 | pantothenate kinase 1 | ![]() |
1 | 1 | |||||||
MIRT120680 | PAK2 | p21 (RAC1) activated kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560855 | OSBPL3 | oxysterol binding protein like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499456 | ODF2L | outer dense fiber of sperm tails 2 like | ![]() |
![]() |
2 | 8 | ||||||
MIRT727038 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
1 | 1 | |||||||
MIRT550470 | OSCAR | osteoclast associated, immunoglobulin-like receptor | ![]() |
![]() |
2 | 4 | ||||||
MIRT051317 | ODC1 | ornithine decarboxylase 1 | ![]() |
1 | 1 | |||||||
MIRT498984 | ORC4 | origin recognition complex subunit 4 | ![]() |
![]() |
2 | 8 | ||||||
MIRT000884 | OMA1 | OMA1 zinc metallopeptidase | ![]() |
![]() |
2 | 1 | ||||||
MIRT326301 | OCRL | OCRL, inositol polyphosphate-5-phosphatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT000886 | OSGEPL1 | O-sialoglycoprotein endopeptidase like 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT110051 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | ![]() |
![]() |
2 | 7 | ||||||
MIRT522098 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 5 | ||||||
MIRT206020 | NUP50 | nucleoporin 50 | ![]() |
![]() |
2 | 7 | ||||||
MIRT152922 | NOL4L | nucleolar protein 4 like | ![]() |
![]() |
2 | 3 | ||||||
MIRT471956 | NR6A1 | nuclear receptor subfamily 6 group A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT727068 | NR2C2 | nuclear receptor subfamily 2 group C member 2 | ![]() |
1 | 1 | |||||||
MIRT727096 | NCOR2 | nuclear receptor corepressor 2 | ![]() |
1 | 1 | |||||||
MIRT004829 | NFKB1 | nuclear factor kappa B subunit 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT472263 | NFIC | nuclear factor I C | ![]() |
![]() |
2 | 2 | ||||||
MIRT547305 | NUCKS1 | nuclear casein kinase and cyclin dependent kinase substrate 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT079655 | NAPG | NSF attachment protein gamma | ![]() |
![]() |
2 | 12 | ||||||
MIRT655815 | NOTCH2 | notch 2 | ![]() |
![]() |
2 | 3 | ||||||
MIRT051348 | NOP2 | NOP2 nucleolar protein | ![]() |
1 | 1 | |||||||
MIRT003885 | NIPAL2 | NIPA like domain containing 2 | ![]() |
![]() |
2 | 1 | ||||||
MIRT518998 | NNT | nicotinamide nucleotide transhydrogenase | ![]() |
![]() |
2 | 4 | ||||||
MIRT051328 | NAB1 | NGFI-A binding protein 1 | ![]() |
1 | 1 | |||||||
MIRT701510 | NEGR1 | neuronal growth regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574595 | N4BP1 | NEDD4 binding protein 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT566654 | NCKAP1 | NCK associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472665 | NAA25 | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT727137 | MTMR4 | myotubularin related protein 4 | ![]() |
1 | 1 | |||||||
MIRT300992 | MTMR3 | myotubularin related protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT506487 | MYO5A | myosin VA | ![]() |
![]() |
2 | 7 | ||||||
MIRT561878 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | ![]() |
![]() |
2 | 2 | ||||||
MIRT000283 | MYB | MYB proto-oncogene, transcription factor | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 3 | |||
MIRT051349 | MYBL1 | MYB proto-oncogene like 1 | ![]() |
1 | 1 | |||||||
MIRT000880 | MSH2 | mutS homolog 2 | ![]() |
![]() |
2 | 1 | ||||||
MIRT702096 | MCFD2 | multiple coagulation factor deficiency 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547406 | MKX | mohawk homeobox | ![]() |
![]() |
2 | 2 | ||||||
MIRT204623 | MOB4 | MOB family member 4, phocein | ![]() |
![]() |
2 | 8 | ||||||
MIRT006181 | MN1 | MN1 proto-oncogene, transcriptional regulator | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT727176 | MLXIP | MLX interacting protein | ![]() |
1 | 1 | |||||||
MIRT286968 | MLLT6 | MLLT6, PHD finger containing | ![]() |
1 | 1 | |||||||
MIRT727701 | FAM73A | mitoguardin 1 | ![]() |
1 | 1 | |||||||
MIRT132831 | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ![]() |
1 | 1 | |||||||
MIRT545190 | MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT566834 | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051334 | MAPK6 | mitogen-activated protein kinase 6 | ![]() |
1 | 1 | |||||||
MIRT727154 | MRPL40 | mitochondrial ribosomal protein L40 | ![]() |
1 | 1 | |||||||
MIRT066291 | MTFR1L | mitochondrial fission regulator 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT077781 | MINK1 | misshapen like kinase 1 | ![]() |
1 | 1 | |||||||
MIRT727198 | MIB1 | mindbomb E3 ubiquitin protein ligase 1 | ![]() |
1 | 1 | |||||||
MIRT550619 | MTHFR | methylenetetrahydrofolate reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT547463 | MBD4 | methyl-CpG binding domain 4, DNA glycosylase | ![]() |
![]() |
2 | 2 | ||||||
MIRT727223 | MED11 | mediator complex subunit 11 | ![]() |
1 | 1 | |||||||
MIRT727228 | MCM3AP-AS1 | MCM3AP antisense RNA 1 | ![]() |
1 | 1 | |||||||
MIRT000878 | MCL1 | MCL1, BCL2 family apoptosis regulator | ![]() |
![]() |
2 | 1 | ||||||
MIRT234342 | MSL1 | male specific lethal 1 homolog | ![]() |
![]() |
2 | 8 | ||||||
MIRT103092 | MAFK | MAF bZIP transcription factor K | ![]() |
![]() |
2 | 5 | ||||||
MIRT522778 | LAMP2 | lysosomal associated membrane protein 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT449190 | LUC7L3 | LUC7 like 3 pre-mRNA splicing factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT571926 | LSM11 | LSM11, U7 small nuclear RNA associated | ![]() |
![]() |
2 | 3 | ||||||
MIRT547546 | LRRFIP2 | LRR binding FLII interacting protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT727297 | LITAF | lipopolysaccharide induced TNF factor | ![]() |
1 | 1 | |||||||
MIRT003883 | C2orf43 | lipid droplet associated hydrolase | ![]() |
![]() |
2 | 1 | ||||||
MIRT728127 | LRIF1 | ligand dependent nuclear receptor interacting factor 1 | ![]() |
1 | 1 | |||||||
MIRT112969 | LUZP1 | leucine zipper protein 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT502038 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT727268 | LRRC57 | leucine rich repeat containing 57 | ![]() |
1 | 1 | |||||||
MIRT727271 | LRPPRC | leucine rich pentatricopeptide repeat containing | ![]() |
1 | 1 | |||||||
MIRT556385 | LURAP1L | leucine rich adaptor protein 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT562031 | LANCL1 | LanC like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474318 | LAMC1 | laminin subunit gamma 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500097 | L2HGDH | L-2-hydroxyglutarate dehydrogenase | ![]() |
![]() |
2 | 8 | ||||||
MIRT437998 | KLF6 | Kruppel like factor 6 | ![]() |
![]() |
2 | 1 | ||||||
MIRT053079 | KLF4 | Kruppel like factor 4 | ![]() |
![]() |
2 | 1 | ||||||
MIRT556861 | KANK1 | KN motif and ankyrin repeat domains 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT727349 | KLC2 | kinesin light chain 2 | ![]() |
1 | 1 | |||||||
MIRT502151 | KIF5B | kinesin family member 5B | ![]() |
![]() |
2 | 9 | ||||||
MIRT152736 | KIF3B | kinesin family member 3B | ![]() |
1 | 1 | |||||||
MIRT506854 | KIF23 | kinesin family member 23 | ![]() |
![]() |
2 | 7 | ||||||
MIRT051327 | KIF1A | kinesin family member 1A | ![]() |
1 | 1 | |||||||
MIRT562881 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497776 | KIAA0895 | KIAA0895 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561153 | KRT33B | keratin 33B | ![]() |
![]() |
2 | 2 | ||||||
MIRT648788 | KLHL40 | kelch like family member 40 | ![]() |
![]() |
2 | 2 | ||||||
MIRT567017 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT170136 | KLHDC10 | kelch domain containing 10 | ![]() |
1 | 1 | |||||||
MIRT727385 | KATNAL1 | katanin catalytic subunit A1 like 1 | ![]() |
1 | 1 | |||||||
MIRT547661 | KPNA3 | karyopherin subunit alpha 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT547702 | KPNA1 | karyopherin subunit alpha 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT000868 | JUN | Jun proto-oncogene, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 1 | ||||||
MIRT513854 | JARID2 | jumonji and AT-rich interaction domain containing 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT324839 | IFT74 | intraflagellar transport 74 | ![]() |
1 | 1 | |||||||
MIRT727426 | IRAK1BP1 | interleukin 1 receptor associated kinase 1 binding protein 1 | ![]() |
1 | 1 | |||||||
MIRT169058 | IRF4 | interferon regulatory factor 4 | ![]() |
1 | 1 | |||||||
MIRT006913 | IFNG | interferon gamma | ![]() |
![]() |
2 | 1 | ||||||
MIRT313675 | ITGA2 | integrin subunit alpha 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475123 | IPPK | inositol-pentakisphosphate 2-kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT092190 | ITPR1 | inositol 1,4,5-trisphosphate receptor type 1 | ![]() |
1 | 1 | |||||||
MIRT051313 | IKBKG | inhibitor of nuclear factor kappa B kinase subunit gamma | ![]() |
1 | 1 | |||||||
MIRT475068 | IVNS1ABP | influenza virus NS1A binding protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT150354 | IER2 | immediate early response 2 | ![]() |
1 | 1 | |||||||
MIRT727483 | HYOU1 | hypoxia up-regulated 1 | ![]() |
1 | 1 | |||||||
MIRT000865 | HSDL2 | hydroxysteroid dehydrogenase like 2 | ![]() |
![]() |
2 | 1 | ||||||
MIRT204592 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | ![]() |
![]() |
2 | 8 | ||||||
MIRT548001 | HCFC2 | host cell factor C2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT172813 | HMBOX1 | homeobox containing 1 | ![]() |
1 | 1 | |||||||
MIRT273665 | HOXC8 | homeobox C8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475539 | HOXA3 | homeobox A3 | ![]() |
![]() |
2 | 8 | ||||||
MIRT541217 | HOXA10 | homeobox A10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003884 | C4orf27 | histone PARylation factor 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT557284 | HIST2H2BE | histone cluster 2 H2B family member e | ![]() |
![]() |
2 | 2 | ||||||
MIRT051316 | HIST1H2BK | histone cluster 1 H2B family member k | ![]() |
1 | 1 | |||||||
MIRT006805 | HMGA2 | high mobility group AT-hook 2 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT006801 | HMGA1 | high mobility group AT-hook 1 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT547968 | HIGD1A | HIG1 hypoxia inducible domain family member 1A | ![]() |
![]() |
2 | 4 | ||||||
MIRT507002 | HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | ![]() |
![]() |
2 | 6 | ||||||
MIRT562204 | HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693934 | HNRNPA1L2 | heterogeneous nuclear ribonucleoprotein A1-like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702879 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475720 | HEYL | hes related family bHLH transcription factor with YRPW motif-like | ![]() |
![]() |
2 | 2 | ||||||
MIRT475843 | HDGF | heparin binding growth factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT000855 | HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT000859 | HERC6 | HECT and RLD domain containing E3 ubiquitin protein ligase family member 6 | ![]() |
![]() |
2 | 1 | ||||||
MIRT211314 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | ![]() |
![]() |
2 | 4 | ||||||
MIRT100364 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
![]() |
3 | 8 | |||||
MIRT000866 | HSPA1A | heat shock protein family A (Hsp70) member 1A | ![]() |
![]() |
2 | 1 | ||||||
MIRT003874 | HSP90B1 | heat shock protein 90 beta family member 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT504855 | HAUS3 | HAUS augmin like complex subunit 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT000857 | HDHD2 | haloacid dehalogenase like hydrolase domain containing 2 | ![]() |
![]() |
2 | 1 | ||||||
MIRT000853 | H3F3B | H3 histone family member 3B | ![]() |
![]() |
2 | 1 | ||||||
MIRT548018 | GRB2 | growth factor receptor bound protein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT165172 | GRAMD3 | GRAM domain containing 2B | ![]() |
![]() |
2 | 3 | ||||||
MIRT000847 | GOLGA5 | golgin A5 | ![]() |
![]() |
2 | 1 | ||||||
MIRT076791 | GOSR1 | golgi SNAP receptor complex member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT000849 | GOLPH3L | golgi phosphoprotein 3 like | ![]() |
![]() |
2 | 1 | ||||||
MIRT727585 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | ![]() |
1 | 1 | |||||||
MIRT727523 | GSK3B | glycogen synthase kinase 3 beta | ![]() |
1 | 1 | |||||||
MIRT051314 | GCLM | glutamate-cysteine ligase modifier subunit | ![]() |
1 | 1 | |||||||
MIRT727605 | GANAB | glucosidase II alpha subunit | ![]() |
1 | 1 | |||||||
MIRT682518 | GLP2R | glucagon like peptide 2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT543839 | GSG1 | germ cell associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT000851 | GTF2H1 | general transcription factor IIH subunit 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT051332 | GDI2 | GDP dissociation inhibitor 2 | ![]() |
1 | 1 | |||||||
MIRT735131 | GSDMB | gasdermin B | ![]() |
![]() |
2 | 0 | ||||||
MIRT727619 | GABARAP | GABA type A receptor-associated protein | ![]() |
1 | 1 | |||||||
MIRT247368 | GABARAPL1 | GABA type A receptor associated protein like 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT297778 | GABPA | GA binding protein transcription factor alpha subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT511847 | GPATCH8 | G-patch domain containing 8 | ![]() |
![]() |
2 | 5 | ||||||
MIRT621501 | GPRC5A | G protein-coupled receptor class C group 5 member A | ![]() |
![]() |
2 | 4 | ||||||
MIRT557484 | GPR27 | G protein-coupled receptor 27 | ![]() |
![]() |
2 | 4 | ||||||
MIRT190184 | GPR180 | G protein-coupled receptor 180 | ![]() |
![]() |
2 | 6 | ||||||
MIRT567450 | GNG12 | G protein subunit gamma 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476259 | GNB1 | G protein subunit beta 1 | ![]() |
![]() |
2 | 7 | ||||||
MIRT540847 | GNAT1 | G protein subunit alpha transducin 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT476276 | GNAL | G protein subunit alpha L | ![]() |
![]() |
2 | 6 | ||||||
MIRT476698 | FURIN | furin, paired basic amino acid cleaving enzyme | ![]() |
![]() |
2 | 2 | ||||||
MIRT727647 | FRYL | FRY like transcription coactivator | ![]() |
1 | 1 | |||||||
MIRT567482 | FZD9 | frizzled class receptor 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT223681 | FZD6 | frizzled class receptor 6 | ![]() |
![]() |
2 | 6 | ||||||
MIRT051345 | FOXO1 | forkhead box O1 | ![]() |
![]() |
![]() |
![]() |
4 | 2 | ||||
MIRT103856 | FOXK1 | forkhead box K1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT518533 | FLCN | folliculin | ![]() |
![]() |
2 | 6 | ||||||
MIRT691713 | FLOT2 | flotillin 2 | ![]() |
![]() |
2 | 3 | ||||||
MIRT548219 | FKBP1A | FK506 binding protein 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT460224 | FGFR4 | fibroblast growth factor receptor 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT006027 | FGF7 | fibroblast growth factor 7 | ![]() |
![]() |
2 | 1 | ||||||
MIRT211199 | FGF2 | fibroblast growth factor 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT071206 | FCF1 | FCF1, rRNA-processing protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT051341 | FASN | fatty acid synthase | ![]() |
![]() |
2 | 5 | ||||||
MIRT003877 | FAM69A | family with sequence similarity 69 member A | ![]() |
![]() |
2 | 1 | ||||||
MIRT550827 | FAM229B | family with sequence similarity 229 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT003879 | FAM122C | family with sequence similarity 122C | ![]() |
![]() |
2 | 1 | ||||||
MIRT502496 | FAM122B | family with sequence similarity 122B | ![]() |
![]() |
2 | 8 | ||||||
MIRT194237 | FAM103A1 | family with sequence similarity 103 member A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT051338 | FBXO3 | F-box protein 3 | ![]() |
1 | 1 | |||||||
MIRT548275 | FBXL20 | F-box and leucine rich repeat protein 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT558041 | EXT1 | exostosin glycosyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658796 | EIF2B2 | eukaryotic translation initiation factor 2B subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT477565 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | ![]() |
![]() |
2 | 8 | ||||||
MIRT000835 | ECHDC1 | ethylmalonyl-CoA decarboxylase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT063394 | ETNK1 | ethanolamine kinase 1 | ![]() |
1 | 1 | |||||||
MIRT551383 | EPM2AIP1 | EPM2A interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537815 | EFNB2 | ephrin B2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT146014 | EZH1 | enhancer of zeste 1 polycomb repressive complex 2 subunit | ![]() |
1 | 1 | |||||||
MIRT727814 | EDC3 | enhancer of mRNA decapping 3 | ![]() |
1 | 1 | |||||||
MIRT102971 | EN2 | engrailed homeobox 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT453288 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT247236 | ELK4 | ELK4, ETS transcription factor | ![]() |
![]() |
2 | 4 | ||||||
MIRT727262 | LYRM5 | electron transfer flavoprotein regulatory factor 1 | ![]() |
1 | 1 | |||||||
MIRT245003 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | ![]() |
1 | 1 | |||||||
MIRT152503 | ENTPD6 | ectonucleoside triphosphate diphosphohydrolase 6 (putative) | ![]() |
1 | 1 | |||||||
MIRT127725 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT502570 | E2F7 | E2F transcription factor 7 | ![]() |
![]() |
2 | 11 | ||||||
MIRT099631 | E2F3 | E2F transcription factor 3 | ![]() |
1 | 1 | |||||||
MIRT575928 | Dmpk | dystrophia myotonica-protein kinase | ![]() |
![]() |
2 | 7 | ||||||
MIRT251487 | DYNLL2 | dynein light chain LC8-type 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT142237 | DCTN5 | dynactin subunit 5 | ![]() |
![]() |
2 | 9 | ||||||
MIRT477849 | DYRK3 | dual specificity tyrosine phosphorylation regulated kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051344 | DSTYK | dual serine/threonine and tyrosine protein kinase | ![]() |
1 | 1 | |||||||
MIRT727856 | DSCR3 | DSCR3 arrestin fold containing | ![]() |
1 | 1 | |||||||
MIRT447778 | DMRT2 | doublesex and mab-3 related transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT736201 | DRD1 | dopamine receptor D1 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT727866 | DNAJC9 | DnaJ heat shock protein family (Hsp40) member C9 | ![]() |
1 | 1 | |||||||
MIRT552039 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499619 | DNAJA1 | DnaJ heat shock protein family (Hsp40) member A1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT000896 | PRIM1 | DNA primase subunit 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT726910 | POLE4 | DNA polymerase epsilon 4, accessory subunit | ![]() |
1 | 1 | |||||||
MIRT544575 | POLDIP3 | DNA polymerase delta interacting protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT509368 | DMPK | DM1 protein kinase | ![]() |
![]() |
2 | 11 | ||||||
MIRT563507 | DLGAP3 | DLG associated protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720153 | PPIP5K2 | diphosphoinositol pentakisphosphate kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT727860 | DPP8 | dipeptidyl peptidase 8 | ![]() |
1 | 1 | |||||||
MIRT727876 | DICER1 | dicer 1, ribonuclease III | ![]() |
1 | 1 | |||||||
MIRT032077 | DLK1 | delta like non-canonical Notch ligand 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT460438 | DOCK11 | dedicator of cytokinesis 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT230120 | DDX3Y | DEAD-box helicase 3, Y-linked | ![]() |
1 | 1 | |||||||
MIRT502643 | DDX3X | DEAD-box helicase 3, X-linked | ![]() |
![]() |
2 | 8 | ||||||
MIRT680986 | DCAF17 | DDB1 and CUL4 associated factor 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT512646 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | ![]() |
![]() |
2 | 5 | ||||||
MIRT164260 | CPEB2 | cytoplasmic polyadenylation element binding protein 2 | ![]() |
1 | 1 | |||||||
MIRT558511 | CYP26B1 | cytochrome P450 family 26 subfamily B member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT727913 | CYB561A3 | cytochrome b561 family member A3 | ![]() |
1 | 1 | |||||||
MIRT189760 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT302611 | CRIM1 | cysteine rich transmembrane BMP regulator 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT327962 | CHIC1 | cysteine rich hydrophobic domain 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT727910 | CYLD | CYLD lysine 63 deubiquitinase | ![]() |
1 | 1 | |||||||
MIRT051321 | CCNYL1 | cyclin Y like 1 | ![]() |
1 | 1 | |||||||
MIRT085215 | CCNT2 | cyclin T2 | ![]() |
1 | 1 | |||||||
MIRT564336 | CCNT1 | cyclin T1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT507853 | CCNE2 | cyclin E2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT001228 | CCNE1 | cyclin E1 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
7 | 10 | |
MIRT168680 | CDKN1A | cyclin dependent kinase inhibitor 1A | ![]() |
1 | 1 | |||||||
MIRT479457 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548946 | CDK17 | cyclin dependent kinase 17 | ![]() |
![]() |
2 | 3 | ||||||
MIRT507820 | CDK1 | cyclin dependent kinase 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT000285 | CCND2 | cyclin D2 | ![]() |
![]() |
![]() |
![]() |
4 | 7 | ||||
MIRT001227 | CCND1 | cyclin D1 | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
6 | 8 | ||
MIRT006658 | Ccnd1 | cyclin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT002946 | DMTF1 | cyclin D binding myb like transcription factor 1 | ![]() |
![]() |
![]() |
![]() |
4 | 4 | ||||
MIRT659260 | CUL3 | cullin 3 | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 2 | |||
MIRT727917 | CUL2 | cullin 2 | ![]() |
1 | 1 | |||||||
MIRT307141 | CTDSPL | CTD small phosphatase like | ![]() |
![]() |
2 | 4 | ||||||
MIRT548727 | CRK | CRK proto-oncogene, adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT006177 | CRKL | CRK like proto-oncogene, adaptor protein | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
6 | 3 | ||
MIRT165883 | CREBRF | CREB3 regulatory factor | ![]() |
![]() |
2 | 3 | ||||||
MIRT727953 | CPNE1 | copine 1 | ![]() |
1 | 1 | |||||||
MIRT005552 | CHUK | conserved helix-loop-helix ubiquitous kinase | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT727924 | CSDE1 | cold shock domain containing E1 | ![]() |
1 | 1 | |||||||
MIRT568143 | CCDC88C | coiled-coil domain containing 88C | ![]() |
![]() |
2 | 2 | ||||||
MIRT545351 | CCDC83 | coiled-coil domain containing 83 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564556 | CCDC80 | coiled-coil domain containing 80 | ![]() |
![]() |
2 | 2 | ||||||
MIRT054424 | CARM1 | coactivator associated arginine methyltransferase 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT558664 | CNKSR3 | CNKSR family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478911 | CPSF7 | cleavage and polyadenylation specific factor 7 | ![]() |
![]() |
2 | 6 | ||||||
MIRT544916 | CLSPN | claspin | ![]() |
![]() |
2 | 2 | ||||||
MIRT568025 | CMTM4 | CKLF like MARVEL transmembrane domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT728092 | C6orf106 | chromosome 6 open reading frame 106 | ![]() |
1 | 1 | |||||||
MIRT640542 | C3orf36 | chromosome 3 open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003878 | C2orf74 | chromosome 2 open reading frame 74 | ![]() |
1 | 1 | |||||||
MIRT728101 | C2orf42 | chromosome 2 open reading frame 42 | ![]() |
1 | 1 | |||||||
MIRT003881 | C17orf80 | chromosome 17 open reading frame 80 | ![]() |
![]() |
2 | 1 | ||||||
MIRT075891 | C16ORF72 | chromosome 16 open reading frame 72 | ![]() |
![]() |
2 | 7 | ||||||
MIRT728133 | C15orf39 | chromosome 15 open reading frame 39 | ![]() |
1 | 1 | |||||||
MIRT549123 | C11orf24 | chromosome 11 open reading frame 24 | ![]() |
![]() |
2 | 4 | ||||||
MIRT267527 | C1ORF226 | chromosome 1 open reading frame 226 | ![]() |
![]() |
2 | 2 | ||||||
MIRT061005 | C1ORF21 | chromosome 1 open reading frame 21 | ![]() |
![]() |
2 | 6 | ||||||
MIRT051330 | CHD4 | chromodomain helicase DNA binding protein 4 | ![]() |
1 | 1 | |||||||
MIRT507877 | CBX6 | chromobox 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541432 | CBX4 | chromobox 4 | ![]() |
![]() |
2 | 3 | ||||||
MIRT289625 | CBX2 | chromobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT006176 | CLCN3 | chloride voltage-gated channel 3 | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT051331 | CLCC1 | chloride channel CLIC like 1 | ![]() |
1 | 1 | |||||||
MIRT265076 | CHEK1 | checkpoint kinase 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT295810 | CHMP4B | charged multivesicular body protein 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT726132 | CHMP3 | charged multivesicular body protein 3 | ![]() |
1 | 1 | |||||||
MIRT051329 | CCT6B | chaperonin containing TCP1 subunit 6B | ![]() |
1 | 1 | |||||||
MIRT114923 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT000831 | CEP63 | centrosomal protein 63 | ![]() |
![]() |
2 | 1 | ||||||
MIRT057514 | CEP55 | centrosomal protein 55 | ![]() |
![]() |
2 | 8 | ||||||
MIRT000829 | CENPJ | centromere protein J | ![]() |
![]() |
2 | 1 | ||||||
MIRT727936 | CREG1 | cellular repressor of E1A stimulated genes 1 | ![]() |
1 | 1 | |||||||
MIRT502922 | CDCA4 | cell division cycle associated 4 | ![]() |
![]() |
![]() |
![]() |
4 | 9 | ||||
MIRT502950 | CDC37L1 | cell division cycle 37 like 1 | ![]() |
![]() |
2 | 9 | ||||||
MIRT728019 | CDC27 | cell division cycle 27 | ![]() |
1 | 1 | |||||||
MIRT000284 | CDC25A | cell division cycle 25A | ![]() |
![]() |
![]() |
![]() |
4 | 4 | ||||
MIRT000827 | CDC14B | cell division cycle 14B | ![]() |
![]() |
2 | 1 | ||||||
MIRT003888 | CADM1 | cell adhesion molecule 1 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT090446 | CDV3 | CDV3 homolog | ![]() |
1 | 1 | |||||||
MIRT154392 | CDS2 | CDP-diacylglycerol synthase 2 | ![]() |
1 | 1 | |||||||
MIRT728006 | CDKN2AIPNL | CDKN2A interacting protein N-terminal like | ![]() |
1 | 1 | |||||||
MIRT549076 | CACUL1 | CDK2 associated cullin domain 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT256305 | CDC42SE2 | CDC42 small effector 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT100896 | CD2AP | CD2 associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT496019 | CD180 | CD180 molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT728047 | CBFA2T3 | CBFA2/RUNX1 translocation partner 3 | ![]() |
1 | 1 | |||||||
MIRT000825 | CARD8 | caspase recruitment domain family member 8 | ![]() |
![]() |
2 | 1 | ||||||
MIRT479988 | CARD10 | caspase recruitment domain family member 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT494354 | CASKIN1 | CASK interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453754 | CSNK1E | casein kinase 1 epsilon | ![]() |
![]() |
2 | 2 | ||||||
MIRT559006 | CA8 | carbonic anhydrase 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT319331 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548809 | CLIP4 | CAP-Gly domain containing linker protein family member 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT000833 | CREBL2 | cAMP responsive element binding protein like 2 | ![]() |
![]() |
![]() |
![]() |
4 | 5 | ||||
MIRT102434 | CALU | calumenin | ![]() |
![]() |
2 | 3 | ||||||
MIRT051326 | CNN3 | calponin 3 | ![]() |
1 | 1 | |||||||
MIRT096234 | CANX | calnexin | ![]() |
![]() |
2 | 2 | ||||||
MIRT514020 | CAMSAP1 | calmodulin regulated spectrin associated protein 1 | ![]() |
![]() |
2 | 5 | ||||||
MIRT051318 | CALD1 | caldesmon 1 | ![]() |
1 | 1 | |||||||
MIRT575886 | Cask | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | ![]() |
![]() |
2 | 4 | ||||||
MIRT508644 | CASK | calcium/calmodulin dependent serine protein kinase | ![]() |
![]() |
2 | 5 | ||||||
MIRT051340 | CABIN1 | calcineurin binding protein 1 | ![]() |
1 | 1 | |||||||
MIRT731341 | CXCL10 | C-X-C motif chemokine ligand 10 | ![]() |
1 | 1 | |||||||
MIRT574207 | CLEC2D | C-type lectin domain family 2 member D | ![]() |
![]() |
2 | 2 | ||||||
MIRT559155 | BTN3A3 | butyrophilin subfamily 3 member A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT061529 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
1 | 1 | |||||||
MIRT051333 | BRWD1 | bromodomain and WD repeat domain containing 1 | ![]() |
1 | 1 | |||||||
MIRT543062 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT003333 | BRCA1 | BRCA1, DNA repair associated | ![]() |
![]() |
2 | 2 | ||||||
MIRT000280 | BMI1 | BMI1 proto-oncogene, polycomb ring finger | ![]() |
![]() |
![]() |
![]() |
![]() |
5 | 3 | |||
MIRT051351 | BTRC | beta-transducin repeat containing E3 ubiquitin protein ligase | ![]() |
1 | 2 | |||||||
MIRT001802 | BACE1 | beta-secretase 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT728237 | B4GALT1 | beta-1,4-galactosyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT000815 | BCL2 | BCL2, apoptosis regulator | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
6 | 13 | ||
MIRT224965 | BAG4 | BCL2 associated athanogene 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT133334 | BCL7A | BCL tumor suppressor 7A | ![]() |
1 | 1 | |||||||
MIRT728194 | BSG | basigin (Ok blood group) | ![]() |
1 | 1 | |||||||
MIRT204741 | BZW1 | basic leucine zipper and W2 domains 1 | ![]() |
![]() |
2 | 12 | ||||||
MIRT092209 | BHLHE40 | basic helix-loop-helix family member e40 | ![]() |
1 | 1 | |||||||
MIRT645514 | BSPRY | B-box and SPRY domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT508041 | AXIN2 | axin 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT481181 | AVL9 | AVL9 cell migration associated | ![]() |
![]() |
2 | 6 | ||||||
MIRT503140 | ATG9A | autophagy related 9A | ![]() |
![]() |
2 | 7 | ||||||
MIRT514042 | ATG14 | autophagy related 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT051337 | ATP6AP1 | ATPase H+ transporting accessory protein 1 | ![]() |
1 | 1 | |||||||
MIRT509693 | ATAD5 | ATPase family, AAA domain containing 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT728265 | ATP13A3 | ATPase 13A3 | ![]() |
1 | 1 | |||||||
MIRT156452 | ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) | ![]() |
![]() |
2 | 2 | ||||||
MIRT484778 | ABCC6 | ATP binding cassette subfamily C member 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT248765 | ATXN7L3B | ataxin 7 like 3B | ![]() |
![]() |
2 | 4 | ||||||
MIRT051320 | ASNSD1 | asparagine synthetase domain containing 1 | ![]() |
1 | 1 | |||||||
MIRT504338 | ASGR2 | asialoglycoprotein receptor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT549278 | ASH1L | ASH1 like histone lysine methyltransferase | ![]() |
![]() |
2 | 3 | ||||||
MIRT461564 | ACTR3B | ARP3 actin related protein 3 homolog B | ![]() |
![]() |
2 | 2 | ||||||
MIRT089206 | ACTR2 | ARP2 actin related protein 2 homolog | ![]() |
![]() |
2 | 3 | ||||||
MIRT000806 | ACTR1A | ARP1 actin related protein 1 homolog A | ![]() |
1 | 1 | |||||||
MIRT568477 | ARMC12 | armadillo repeat containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT072822 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 5 | ||||||
MIRT189961 | AGO4 | argonaute 4, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT482370 | AGO2 | argonaute 2, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT129055 | ARCN1 | archain 1 | ![]() |
1 | 1 | |||||||
MIRT727719 | AMER1 | APC membrane recruitment protein 1 | ![]() |
1 | 1 | |||||||
MIRT646599 | ANKRD36 | ankyrin repeat domain 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT145377 | ANKRD13B | ankyrin repeat domain 13B | ![]() |
1 | 1 | |||||||
MIRT618900 | ANKMY1 | ankyrin repeat and MYND domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT061244 | AMOTL1 | angiomotin like 1 | ![]() |
![]() |
2 | 12 | ||||||
MIRT549389 | AMOT | angiomotin | ![]() |
![]() |
2 | 2 | ||||||
MIRT003887 | ANAPC16 | anaphase promoting complex subunit 16 | ![]() |
![]() |
2 | 1 | ||||||
MIRT543411 | ANAPC13 | anaphase promoting complex subunit 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003899 | APP | amyloid beta precursor protein | ![]() |
![]() |
![]() |
![]() |
4 | 3 | ||||
MIRT576593 | Npepps | aminopeptidase puromycin sensitive | ![]() |
![]() |
2 | 2 | ||||||
MIRT510047 | AKR1B10 | aldo-keto reductase family 1 member B10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT451839 | ALDH3B1 | aldehyde dehydrogenase 3 family member B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT003334 | AKT3 | AKT serine/threonine kinase 3 | ![]() |
![]() |
![]() |
3 | 6 | |||||
MIRT568575 | AHNAK2 | AHNAK nucleoprotein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT728384 | AFF4 | AF4/FMR2 family member 4 | ![]() |
1 | 1 | |||||||
MIRT616471 | ADRA2B | adrenoceptor alpha 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT717465 | ADORA3 | adenosine A3 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT000819 | ASXL2 | additional sex combs like 2, transcriptional regulator | ![]() |
![]() |
2 | 1 | ||||||
MIRT728290 | ASXL1 | additional sex combs like 1, transcriptional regulator | ![]() |
1 | 1 | |||||||
MIRT544593 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT728330 | AP3M1 | adaptor related protein complex 3 mu 1 subunit | ![]() |
1 | 1 | |||||||
MIRT728400 | ACOX1 | acyl-CoA oxidase 1 | ![]() |
1 | 1 | |||||||
MIRT568621 | ACVR2A | activin A receptor type 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT051312 | ACVR1B | activin A receptor type 1B | ![]() |
1 | 1 | |||||||
MIRT051336 | ATF2 | activating transcription factor 2 | ![]() |
1 | 1 | |||||||
MIRT446508 | ASCC1 | activating signal cointegrator 1 complex subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482556 | ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | ![]() |
![]() |
2 | 10 | ||||||
MIRT482581 | ABHD2 | abhydrolase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT068655 | AKAP11 | A-kinase anchoring protein 11 | ![]() |
1 | 1 | |||||||
MIRT003876 | NT5DC1 | 5'-nucleotidase domain containing 1 | ![]() |
![]() |
2 | 1 | ||||||
MIRT545686 | DECR1 | 2,4-dienoyl-CoA reductase 1 | ![]() |
![]() |
2 | 2 |